Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
WFDC1
REST API REST API
Homo sapiens
WFDC1 is differentially expressed in 194 experiments: 135 organism parts: cerebellum, prostate, ... (133 more);, 173 disease states: normal, colon carcinoma, ... (171 more);, 61 cell types 166 cell lines 17 compound treatments and 59 other conditions.
Synonyms PS20
Orthologs WFDC1_CHICK (Gallus gallus)   Wfdc1 (Mus musculus)   ENSCING00000013443 (Ciona intestinalis)   wfdc1 (Danio rerio)   Wfdc1 (Rattus norvegicus)   wfdc1 (Xenopus laevis)   WFDC1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term negative regulation of cell growth, serine-type endopeptidase inhibitor activity, extracellular space, peptidase inhibitor activity, extracellular region, molecular_function, regulation of cell growth, response to drug, negative regulation of epithelial cell proliferation, response to estradiol stimulus
InterPro Term Whey_acidic_protein_4-diS_core
UniProt Accession Q9HC57
Search EB-eye ENSG00000103175
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-17189, E-GEOD-803, E-AFMX-5, E-GEOD-6573, E-MEXP-1251, ... (24 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-3860, E-GEOD-5258, E-GEOD-19397, E-GEOD-2450, E-MTAB-62, ... (25 experiments)

Factor Value U/D Experiments
MCF7
2
 E-GEOD-5258, E-MTAB-37
ANBL-6
1
 E-MEXP-921
GM13883
1
 E-TABM-321
a549
1
 E-MTAB-62
gm00316b, fibroblast cell line
1
 E-MTAB-62
k562
1
 E-MTAB-62
160 more value(s).


Cell type

studied in E-GEOD-3920, E-MEXP-66, E-GEOD-13987, E-GEOD-3998, E-GEOD-19240, ... (32 experiments)

Factor Value U/D Experiments
stromal cell
3
 E-MEXP-2034, E-MEXP-1327, E-GEOD-3998
CD8+ T cell
2
 E-MTAB-25, E-AFMX-5
CD4+ T cell
1
2
 E-MEXP-1600, E-MTAB-24, E-MTAB-25
macrophage
1
 E-GEOD-8286
hematopoietic stem cell
1
 E-MEXP-872
type II helper T cell
1
 E-GEOD-3982
55 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-TABM-15, E-MEXP-2280, E-GEOD-16363, ... (52 experiments)

Factor Value U/D Experiments
colon carcinoma
4
 E-GEOD-3726, E-MTAB-62, E-MTAB-57, E-MTAB-37
prostate carcinoma
4
 E-MTAB-62, E-TABM-26, E-MEXP-2034, E-MEXP-1327
benign prostatic hyperplasia
3
 E-GEOD-7307, E-MEXP-2034, E-GEOD-5377
septic shock
2
 E-GEOD-9692, E-GEOD-8121
AIDS-KS, HIV+, nodular (late) stage
2
 E-MEXP-66, E-MTAB-62
adrenocortical carcinoma
2
 E-GEOD-10927, E-TABM-311
167 more value(s).


Compound treatment

studied in E-GEOD-1615, E-MEXP-1269, E-GEOD-3284, E-TABM-782, E-GEOD-7216, ... (11 experiments)

Factor Value U/D Experiments
BCR/FGFR1
1
 E-GEOD-15811
valproic acid
1
 E-GEOD-1615
bacterial endotoxin
1
1
 E-GEOD-3284
estradiol
1
 E-GEOD-20081
ethanol
1
 E-MEXP-2241
AMP
1
 E-MEXP-2285
11 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
 E-GEOD-19519
tunicamycin
1
 E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-2171, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-MEXP-1828, E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-MEXP-1251, ... (8 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-GEOD-2666, E-MEXP-958, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-MEXP-2280, E-GEOD-21138, E-GEOD-19665 ... (5 experiments)

Environmental stress
studied in E-GEOD-1518

Epiregulin elisa conc ng ml
studied in E-GEOD-5851

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-7011, E-GEOD-7578, E-MEXP-563

Genotype
studied in E-TABM-1029, E-GEOD-22056, E-GEOD-17476, E-GEOD-2725, E-MEXP-1403 ... (5 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-GEOD-5681, E-GEOD-12773, E-GEOD-20540, E-GEOD-9764, ... (8 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-5764, E-TABM-176, E-MEXP-2069, ... (22 experiments)

Infection
studied in E-GEOD-12108, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056

Labeling
studied in E-LGCL-5

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-2487, E-MEXP-1403

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

Qpcr egfr dct
studied in E-GEOD-5851

Replicate
studied in E-GEOD-10797, E-GEOD-10896

RNAi
studied in E-MEXP-101, E-MEXP-548, E-GEOD-3697, E-MEXP-1315

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-7307

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Treatment
studied in E-GEOD-16837, E-GEOD-21909

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290

Processing time: 0.515 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM